Notice of Proposed Sale · 144
RxSight, Inc.
RXSTNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- RxSight, Inc.
- Issuer CIK
- 0001111485
- SEC file number
- 001-40690
- Phone
- 949-521-7822
- Person for whose account securities are to be sold
- Weinberg Eric
- Relationships to issuer
- Officer
- Street
- 100 COLUMBIA STREET
- Street (continued)
- SUITE 120
- City
- ALISO VIEJO
- State / country code
- CA
- Postal code
- 92656
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common Stock | 2,041 | 14,205.36 | 41,593,256 | 09/02/2026 | NASDAQ | E-Trade Financial Corporation |
Broker / market maker — proposed row 1, entry 1
- Name
- E-Trade Financial Corporation
- Street
- 3 Edison Drive
- City
- Alpharetta
- State / country code
- GA
- Postal code
- 30005
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common Stock | 08/31/2026 | Restricted Stock Units | Issuer | 5,370 | N | 08/31/2026 | N/A |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Remarks
Shares to be sold to cover withholding taxes upon vesting of restricted stock unit awards
Notice signature
- Notice date
- 09/02/2026
- Signed
- /s/ Jim Schindler, as Attorney-in-Fact
Filed exhibits
- EX-24 ↗ewpoa.pdf
Company context
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The Light Adjustable Lens™ system, comprised of the RxSight Light Adjustable Lens™ products (LAL™ and LAL+™), RxSight Light Delivery Device™ (LDD™), and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.